Log in

OTCMKTS:FUTUFuture Healthcare of America Stock Price, Forecast & News

$29.77
+0.20 (+0.68 %)
(As of 07/15/2020 04:00 PM ET)
Add
Compare
Today's Range
$28.61
Now: $29.77
$30.45
50-Day Range
$14.55
MA: $22.36
$31.51
52-Week Range
$8.16
Now: $29.77
$33.80
Volume738,900 shs
Average Volume452,159 shs
Market Capitalization$3.31 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Natur Holdings B.V. produces health food, such as natural juices and snacks. The company is based in Amsterdam, the Netherlands.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.82 out of 5 stars


Industry, Sector and Symbol

Industry Security brokers & dealers
Sub-IndustryN/A
Current SymbolOTCMKTS:FUTU
CUSIPN/A
Phone852-2523-3588

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$3.31 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive FUTU News and Ratings via Email

Sign-up to receive the latest news and ratings for FUTU and its competitors with MarketBeat's FREE daily newsletter.

Future Healthcare of America (OTCMKTS:FUTU) Frequently Asked Questions

How has Future Healthcare of America's stock been impacted by COVID-19 (Coronavirus)?

Future Healthcare of America's stock was trading at $11.52 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, FUTU shares have increased by 158.4% and is now trading at $29.77. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Future Healthcare of America?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Future Healthcare of America in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Future Healthcare of America.

How were Future Healthcare of America's earnings last quarter?

Future Healthcare of America (OTCMKTS:FUTU) posted its earnings results on Thursday, May, 14th. The health services provider reported $0.16 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.72 by $0.56. The health services provider earned $63.30 million during the quarter. View Future Healthcare of America's earnings history.

What price target have analysts set for FUTU?

1 Wall Street analysts have issued twelve-month price objectives for Future Healthcare of America's stock. Their forecasts range from $17.90 to $17.90. On average, they anticipate Future Healthcare of America's stock price to reach $17.90 in the next twelve months. This suggests that the stock has a possible downside of 39.9%. View analysts' price targets for Future Healthcare of America.

Has Future Healthcare of America been receiving favorable news coverage?

Headlines about FUTU stock have trended positive this week, InfoTrie reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Future Healthcare of America earned a media sentiment score of 2.1 on InfoTrie's scale. They also assigned media headlines about the health services provider a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the next several days. View the latest news about Future Healthcare of America.

Who are some of Future Healthcare of America's key competitors?

What other stocks do shareholders of Future Healthcare of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Future Healthcare of America investors own include Amplify Energy (AMPY), Amplify Energy (AMPY), Alexco Resource (AXU), Biocept (BIOC), Blackrock Capital Investment (BKCC), Goodrich Petroleum (GDP), Goodrich Petroleum (GDP), Gold Standard Ventures (GSV), Gold Standard Ventures (GSV) and InterCloud Systems (ICLD).

Who are Future Healthcare of America's key executives?

Future Healthcare of America's management team includes the following people:
  • Ms. Ellen Berkers, CEO, CFO & Director (Age 45)
  • Robert Jan van Olm, Chief Commercial Officer

What is Future Healthcare of America's stock symbol?

Future Healthcare of America trades on the OTCMKTS under the ticker symbol "FUTU."

Who are Future Healthcare of America's major shareholders?

Future Healthcare of America's stock is owned by many different institutional and retail investors. Top institutional shareholders include MERIAN GLOBAL INVESTORS UK Ltd (0.02%) and Envestnet Asset Management Inc. (0.01%). View institutional ownership trends for Future Healthcare of America.

Which institutional investors are buying Future Healthcare of America stock?

FUTU stock was purchased by a variety of institutional investors in the last quarter, including MERIAN GLOBAL INVESTORS UK Ltd, and Envestnet Asset Management Inc.. View insider buying and selling activity for Future Healthcare of America.

How do I buy shares of Future Healthcare of America?

Shares of FUTU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Future Healthcare of America's stock price today?

One share of FUTU stock can currently be purchased for approximately $29.77.

How big of a company is Future Healthcare of America?

Future Healthcare of America has a market capitalization of $3.31 billion.

What is Future Healthcare of America's official website?

The official website for Future Healthcare of America is www.futuholdings.com.

How can I contact Future Healthcare of America?

Future Healthcare of America's mailing address is 11/F Bangkok Bank Building No. 18 Bonham Strand W Sheung Wan, Hong Kong K3, . The health services provider can be reached via phone at 852-2523-3588 or via email at [email protected]

This page was last updated on 7/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.